Summary: In epidemiology, identifying the effect of exposure variables in relation to a time-to-event outcome is a classical research area of practical importance. Incorporating propensity score in the Cox regression model, as a measure to control for confounding, has certain advantages when outcome is rare. However, in situations involving exposure measured with moderate to substantial error, identifying the exposure effect using propensity score in Cox models remains a challenging yet unresolved problem. In this paper, we propose an estimating equation method to correct for the exposure misclassification-caused bias in the estimation of exposure-outcome associations. We also discuss the asymptotic properties and derive the asymptotic variances of the proposed estimators. We conduct a simulation study to evaluate the performance of the proposed estimators in various settings. As an illustration, we apply our method to correct for the misclassification-caused bias in estimating the association of PM2.5 level with lung cancer mortality using a nationwide prospective cohort, the Nurses' Health Study (NHS). The proposed methodology can be applied using our user-friendly R function published online.
Introduction
Propensity score (PS) method is widely used to control for confounding in epidemiological studies (Rosenbaum and Rubin, 1983) . It has advantages over using standard multivariate adjustment method (Glynn et al., 2006) . In studies with rare outcomes, for example, etiological studies for rare cancers or cancer subtypes, the disease prevalence could be low. As a result, there could be no events in some strata of covariates. Since exposure prevalence is not necessarily as low, the zero event problem is unlikely to occur when regressing exposure on the other covariates. With a relatively large number of model covariates and a small number of events, the PS method makes it possible to control for confounding when standard multivariate analysis fails. Cepeda et al. (2003) proposed a rule stating that when there are fewer than eight outcomes per covariate, PS method should be considered. Another advantage of using PS is that it allows more flexible modeling since one can fit a complicated PS model with interactions and higher order terms of confounders without requiring models for the confounder-outcome association (D'Agostino, 1998) . PS can be used to adjust for confounding through matching, stratification, inverse probability of treatment weighting (IPTW), and regression modeling (D'Agostino, 1998) . This paper focuses on time-to-event data settings. We study the exposure-outcome association based on the Cox proportional hazards (PH) model (Cox, 1972) where the binary exposure is subjected to misclassification. Methods to deal with error-prone covariates in the PS model include a casual graph model method (Kuroki and Pearl, 2014; Pearl, 2010) , an inverse probability weighting method for the additive measurement error in covariates (McCaffrey et al., 2013) , and a Bayesian method for differential covariates measurement errors across treatment groups (Hong et al., 2016) . However, none of the methods above considers the presence of misclassification in the exposure, which is the dependent variable in the PS model. A recent paper (Braun et al., 2017) focuses on error-prone exposures in a survival analysis context, which is based on PS implementations of the subclassification, matching, and IPTW approaches, but not the regression modeling approach. As discussed in Shah et al. (2005) , among studies using PS to adjust for confounders, the majority of them include PS in regression models. In this paper, we focus on exposure misclassification problems when including PS in regression models.
In this paper, we propose an estimating function method for handling the exposure misclassification problems in time-to-event data settings where the PS is included in the Cox model to adjust for potential confounders. The paper is organized as follows. In Section 2, we present our new method. In Section 3, we conduct a simulation study to evaluate the finite sample performance of our method. In Section 4, we apply the proposed method to evaluate the association of PM 2.5 with lung cancer mortality in the Nurses' Health Study (NHS). We present a discussion in Section 5.
Method

Modified partial likelihoods
We consider the time-to-event data settings, in which there is a binary exposure subject to misclassification, and there are a vector of potential confounders, denoted as W, measured without error. Without further specification, all vectors are column vectors in this paper.
Let X be the true exposure, and Z be the misclassified version of X. Let Y = (T , δ), wherẽ T = min(T, C), T is the time to event of interest, C is the censoring time, and δ = I{T = T }.
We assume the following Cox PH model conditional on the true exposure:
where subscript i refers to the ith individual, superscript t represents transpose, λ i (t) is the hazard rate at time t, λ 0 (t) is the baseline hazard at time t, and β, the log-hazard ratio (HR) representing the exposure-disease association, is the parameter of interest. If X is available, the PS for the ith individual is defined as P (X i = 1|W i ; α x ), denoted as 
). If we use the PS approach to control for the potential confounders, the Cox PH model has the following form:
In a main study/external validation study (MS/EVS) design, Y , Z and W are available in the main study, and X, Z and W are available in the external validation study. That is, the misclassified version of the exposure is observed in both the main study and the validation study while the true exposure is only observed in the validation study. Transportability, which means that the misclassification/measurement error model in the validation study is the same as that in the main study, is required for the MS/EVS design (Weller et al., 2007; Rosner et al., 1990 ). We will use V to denote the set of subjects in the validation study and V c to denote the set of subjects not in the validation study (i.e., in the main study).
Under the surrogacy assumption λ i (t|X i , Z i , W i ) = λ(t|X i , W i ), the partial likelihood based on the surrogate Z can be written as (Prentice, 1982) 
Writing out λ i (t|X i , W i ) as in model (1), and denoting exp(
we have
Assuming censoring is independent from both the event time and the surrogate, it follows that, under the MS/EVS design, the partial likelihood is
where D is the set including all the participants with events, t i is the observed event time for individual i, R(t i ) is the risk set at t i , and
For presentational simplicity, we have assumed there are no ties.
In the main study/internal validation study (MS/IVS) design, in addition to X, Z and W, Y is also available in the validation study, and transportability is ensured. Information about the covariates-outcome relationship in the internal validation study contributes to the hazard ratio estimate. The partial likelihood for the MS/IVS design is:
Under the rare event assumption, we can omit
That is, e j (t i ) can be approximated bỹ
We denote P (X|Z, W ) as p X,Z (γ, W ) hereafter, where γ represents a vector of unknown parameters. For example, we could assume the following logistic regression model,
where γ can be estimated using the validation study. It follows that likelihood L I 1 above can be approximated under the rare event assumption by
. In e j (t i ) in (2) andẽ j above, α x in P S X (α x , W) cannot be estimated from the main study (V c ) as X is unobserved. However, since P S X can be written as
where P S Z (α z , W ) = P (Z = 1|W ; α z ). Note that P S X involves the vector of parameters α x , and P S XC involves α z and γ.
In the MS/IVS design, where the validation study is a random sample of the full study, it is reasonable to assume that the distributions of X|W and Z|W are transportable from the validation study to the main study. Therefore, α x in the model for X|W can be estimated using the validation study, and α z in the model for Z|W can be estimated using both the validation study sample V and the main study sample V c . However, for cohort studies, typically, the validation study size is small, and the number of unknown parameters in the PS model is large. Thus, it is typically less efficient to fit the PS model X|W than to fit Z|W and use P S XC .
In the MS/EVS design, transportability for the distribution of X|W or Z|W typically does not hold. Thus, α x is not available, and α z in P S Z can be estimated using data from the main study (V c ).
Therefore, under the rare disease/event assumption, we propose the following modified partial likelihoods, which use P S XC instead of P S X .
For MS/EVS:
wherẽ
For MS/IVS:
where
Next, we propose two methods for making inferences on β based on L E * 1 and L I * 1 above.
Estimating equations and asymptotic properties
For the MS/EVS design, the modified partial score for ψ = (β, β p ), derived by taking the first derivation of log L E * 1 with respect to ψ, where L E * 1 is defined in (4), can be written as
represents the time at the end of the study, N i (t) is the counting process for the ith individual in the main study, Y i (t) is a risk set indicator (1=being in the risk set at t), n V c is the sample size of the main study (V c ), and for any vector B,
and
For the MS/IVS design, from (5), the modified score function can be written as
and n is the sample size of the entire study. Let
Next, we consider the estimating functions for the misclassification parameters. For example, if we use model (3) for P (X|Z, W ), the corresponding likelihood is
with γ = (γ 0 , γ 1 , γ 2 ), which involves only the validation study data. The score function, denoted asŨ 2,γ (γ), can be derived accordingly. Very often, it is reasonable to assume γ 2 = 0; that is, given Z, W does not have additional information about X. If γ 2 = 0, γ = (γ 0 , γ 1 ) in model (3) is a reparameterization of the positive predictive value (PPV), P (X = 1|Z = 1), and negative predictive value (NPV), P (X = 0|Z = 0). Let U 2,γ (γ) = n −1
We can use the logistic regression to estimate P S Z by assuming
with α z = (α z0 , α z1 ). The corresponding likelihood is then
where H = V c for the MS/EVS design and H = V c ∪ V for the MS/IVS design. This likelihood involves only the main study data (V c ) for the MS/EVS design and involves both the main and validation studies (V c ∪ V ) for the MS/IVS design. The score function, denoted as
for the MS/EVS design, and U 3,αz (α z ) = n −1Ũ
3,αz (α z ) = n −1 i∈V c ∪VŨ 3i,αz (α z ) for the MS/IVS design.
We propose the following estimating function in order to obtain the inferences for the vector of parameters ψ:
Solving g = 0 for ψ, γ and α z simultaneously is equivalent to the two-stage approach, where, in the first stage, we obtain the estimatorsγ andα z by solving U 2,γ = 0 (or maximizing L 2 (γ)) and U 3,αz = 0 (or maximizing L 3 (α z )), respectively, and in the second stage we obtain the estimatorψ = (β,β p ) by maximizing the pseudo-modified partial likelihood
The approximate consistency of the resulting point estimatorψ follows from Andersen and Gill (1982) and Tsiatis (1981) . Under mild regularity conditions,ψ P → ψ * , with ψ * a well defined constant vector that reasonably approximates ψ (Struthers and Kalbfleisch, 1986).
The asymptotic index is n V c → ∞ and n V → ∞, with the ratio n V c /n V bounded by finite numbers. The proof is outlined in Appendix A. In Appendix B, we prove the asymptotic normality,
for the MS/IVS design. We can estimate the variances of the proposed estimators using the following sandwich estimator:
where ∇ ψ represents the first derivative with respect to parameter ψ, h = E or I, and
with G i , C γ and C αz given in the Appendix B.
Simulation Study
We conducted a simulation study to evaluate the finite sample performance of our method under the MS/EVS and MS/IVS designs.
In the generated samples, we assumed there was a true binary exposure X, a surrogate Z, and a single binary confounder W with a prevalence P (W = 1) = 0.5. The main study sample size (n V C ) was 2,000 or 10,000, and the validation study size (n V ) was 200 or 500.
The underlying effect of X, W on survival time followed the Cox regression model with coefficients for X, β = log(1.2) or log(1.5) and that for W , β W = log(1.3). Time until event was generated based on the exponential distribution. Time of censoring was uniformly distributed in the interval (0, b). Different values of b corresponded to different outcome prevalences. The values of surrogate variable Z were generated based on values of X with one of the four combinations of sensitivity and specificity, (0.8, 0.8), (0.6, 0.8), (0.8, 0.6) and (0.6, 0.6). Note that under these settings, both PPV and NPV ranged from 0.6 to 0.8.
We compared the averaged percent biases of the estimated coefficients,β, over 1,000 simulation replicates using each of the following methods, the one using true exposure X and the propensity score P S X , the naive approach using Z and the crude propensity score P S Z , and the proposed estimating equation method based on (8). We also assessed 95% confidence interval (CI) coverage probabilities of the interval estimates for the estimating equation method. The results for an event prevalence of 5% under the MS/EVS design are presented in Table 1 . The results under the MS/IVS design, based on L I * 1 in (5), are in Table 2 . As shown in the simulation study results, our estimating equation method substantially reduced the bias in the naiveβ-estimators. As expected, when the main study sample size increased from 2,000 to 10,000, the estimating equation method led to estimates with smaller biases and significantly better coverage rates regardless of the effect sizes. When the validation study sample size increased from 200 to 500, the biases in the estimating equation-estimators were reduced in a majority of the simulation scenarios (7 out of 12).
[ coverage rates were 96% or 97% when the main study sample size was 10,000, and ranged from 97% to 100% when the main study sample size was only 2,000. These simulation results suggest that, when the event prevalence is very low, a relatively large sample size is required in order to have a sufficient number of events for obtaining satisfactory estimates.
The simulation results in non-rare event scenarios (25% event prevalence) are presented in Web Supplementary Table 3 . The absolute values of the percent biases were below 5% in all of the simulation scenarios. The 95% CI coverage probabilities were in the range of 94%-96% in 11 out of 16 simulation scenarios, and in the other 5 simulation scenarios, where the coverage rates were in 91%-93% or 97%-98%, either the main study sample size was only 2000 or the validation study sample size was only 200.
Illustrative Example
In this section, we present a real data example for illustrative purposes. Our example is based on the all-female Nurses' Health Study (NHS), an nationwide prospective cohort of 121,700 female nurses enrolled in 1976 when aged between 30 and 55 years. The participants were initially recruited from 11 states, but now reside in all 50 U.S. states. Participants completed mailed questionnaires biennially to report risk factors and new diagnoses of health outcomes.
The response rates were above 90% for each follow-up cycle. We considered the relationship between baseline PM 2.5 exposure and lung cancer mortality. The follow-up period considered was from 2000 through 2010. We excluded all women who were dead or had a previous diagnosis of cancer (except for non-melanoma skin cancer) before the follow-up period or did not have information for the exposures of interest, resulting in 96,295 participants and 1199 lung cancer deaths.
The exposure of interest was PM 2.5 , dichotomized to 15µg/m 3 vs. > 15µg/m 3 . The sur-rogate exposure was the ambient geographic information system (GIS)-based spatiotemporal exposure model predictions of PM 2.5 (Weuve et al., 2012; Yanosky et al., 2014) corresponding to the latitude and longitude of residential address of the participants for the year 2000.
In an external validation study, PM 2.5 was measured by personal monitors continuously between 1998-2002 in nine cities in the United States (Kioumourtzoglou et al., 2014) . The measurement error associated with the monitoring devices was relatively small compared to the error in the surrogates described above (Chakrabarti et al., 2004; Lee, et al., 2006) , and the PM 2.5 measurement based on these personal monitors was treated as the gold standard.
The total number of participants in this validation study was 1,029, with sampling session durations between 2 to 12 days. The estimated PPV and NPV from this validation study were 0.6232 and 0.5206, respectively.
The analyses were based on the proportional hazard regression model with age as the time scale; left truncation was taken into account when determining each risk set. The potential confounders adjusted for in the analyses included the following baseline covariates: calendar year, race (Caucasian, other), regions (Northeast, Midwest, West, South), BMI (< 18.5, >= 18.5, < 27.5 , >= 27.5 kg/m 2 ), census-tract median household income (quartiles), censustract median home value (quartiles), pack-years of smoking (continuous), smoking status (never smoker, quit smoking >= 10 years, current or smoked in the last 10 years), month since quit smoking (continous), secondhand smoking (no parent smoke, mother smoke, father smoke, both smoke), second hand smoking at home or work (none, occasional, regular), occupational secondhand smoke (none, occasional, regular), years living with someone who smokes(continues), registered nurse degree (binary), physical activity amount (< 3, 3 to < 18, >= 18 MET hr/week), alcohol consumption ( <= 1, 1 to <= 2, >2 drink/day), cumulative updated HDS-2010 diet score (quartiles), hypercholesterolemia (binary), diabetes (binary), hypertension (binary), mother's job (housewife, outside job), father's job (professional or manager, other job, no job), marital status (married, not), husbands education (less than high school, high school, greater than high school). A missing indicator variable (Huberman and Langholz, 1999) was also included for each of the potential confounders with missingness. [ Table 3 about here.]
Discussion
For the Cox model analysis including a PS in the regression model to adjust for potential confounders, our semiparametric method developed in this paper corrects for the exposure misclassification-caused bias in the estimator of the exposure-outcome association. The proposed method applies to both the MS/IVS and MS/EVS designs. A user-friendly R program implementing the new method is available at http://www.hsph.harvard.edu /molinwang/software.
We focused on time-independent exposures in this paper. A potential topic for future research is to extend the method to incorporate time-varying exposures.
Supplementary Materials
Web Supplementary tables referenced in Sections 3 are available with this article at the Biometrics website on the Wiley Online Library. and
represents the true parameters, and λ 0 (t)E{exp(β
representing the first derivative with respect to parameter θ. We assume the following mild regularity conditions:
(a2) s (m) (ψ, η, t), m = 0, 1, 2 are continuous and bounded functions of ψ, for any ψ and η in the neighborhoods Ψ and Ω of ψ * and β * , respectively, and for t ∈ [0, T 0 ]. Also,
is bounded away from zero.
(a3) The matrix I ψ (ψ, η) is continuous in ψ and positive definite at ψ * .
By the Weak Law of Large Numbers, sup
Under the regularity conditions above, it was showed by Andersen and Gill (1982) ; Lin and Wei (1989) that
Recall thatψ is the solution of U 1,ψ (ψ,η) = 0, and we have U 1,ψ (ψ,η) = U 1,ψ (ψ, η * ) + o p (1), due to Assumption (a1) and since a i is bounded for finite values of ψ. Let ψ * be the solution to u(ψ, η * ) = 0. By the assumptions above including (a3), we haveψ P → ψ * .
Appendix B: Asymptotic normality
First consider the MS/EVS design. By the Taylor expansion, we have
Under the assumptions above, we have
by following the proof in Andersen and Gill (1982) and Lin and Wei (1989) . Similarly,
Then following the proof in Lin and Wei (1989) , we can show that n Under Condition (a1), we may write
Substituting these into (A.1) we obtain
where C γ (ψ, η) = ∇ γ U 1,ψ (ψ, η)[∇ γ U 2,γ (γ)] −1 and C αz (ψ, η) = ∇ αz U 1,ψ (ψ, η)[∇ αz U 3,αz (α z )] −1 . Table 1 MS/EVS; 5% event prevalence; percent bias and empirical standard error (ESE) for β-estimates based on the method using true exposure X and propensity score P S X (No ME), the naive method using Z and P S Z , and the estimating equation (EE) method; 95% confidence interval coverage rate (CR) for the EE method
No ME Naive EE Method Table 2 MS/IVS; 5% event prevalence; percent bias and empirical standard error (ESE) for β-estimates based on the method using true exposure X and propensity score P S X (No ME), the naive method using Z and P S Z , and the estimating equation (EE) method based on L I * 1 ; 95% confidence interval coverage rate (CR) for the EE method
No ME Naive EE Method 
